Introducing Kikoko's Little Helpers - Cannabis-infused botanical mints. Kikoko Little helpers are packed with micro-dosed, cannabinoids, vitamins, and plant adaptogens. Tiny in size, the mints are discreet and perfect for someone whose on-the-go. A heavenly bite to send you to dreamland. With organic peppermint (a stomach and digestive aid) Rose (a stress reliever), Chamomile (a sedative), and Black Pepper Extract (increases absorption of phytochemicals), these mints contain 3MG CBN (the cannabinoid that helps you sleep), 2MG THC and 1MG melatonin.
Little Helpers are sugar-free, dairy-free, gluten-free, and vegan!
Introducing Kikoko's Little Helpers - Cannabis-infused botanical mints. Kikoko Little helpers are packed with micro-dosed, cannabinoids, vitamins, and plant adaptogens. Tiny in size, the mints are discreet and perfect for someone whose on-the-go. A heavenly bite to send you to dreamland. With organic peppermint (a stomach and digestive aid) Rose (a stress reliever), Chamomile (a sedative), and Black Pepper Extract (increases absorption of phytochemicals), these mints contain 3MG CBN (the cannabinoid that helps you sleep), 2MG THC and 1MG melatonin.
Little Helpers are sugar-free, dairy-free, gluten-free, and vegan!
No product reviews
Have you tried this product? Be the first to leave a review!
Kikoko is a women-owned, women-run company inspired by a friend who battled cancer. Our founders noticed a lack of properly dosed edibles with high-quality ingredients, and they set out with a mission to create alternatives to pharmaceuticals and alcohol. Our organic, clinically dosed, cannabis-infused products are for people who value wellness and high-quality ingredients. Kikoko makes herbal teas, tinctures, mints, and HoneyShots. Based on clinical research, each product line is designed to solve a problem, pairing thoughtful cannabinoid ratios, synergistic herbs, vitamins, and adaptogenic ingredients for sleep, anxiety, mood, sex, and pain. We are committed to sustainability and making an impact, and we donate a portion of our annual revenue to initiatives that promote cannabis research and reform, such as the Last Prisoner Project.
